Close
Almac
Achema middle east

Xcellerex launches new bag-type XDR-10 single-use bioreactor

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

UK Plans to Produce Cancer Treatment from Nuclear Waste

Bicycle Therapeutics has entered into a 15-year agreement with...

Pfizer Signs Around $2.1bn Licensing Deal with YaoPharma

Pfizer has confirmed that it has struck an almost...

€47mn as State Aid for New Aseptic Filling Plant from Vetter

The European Commission has stepped up and given the...
- Advertisement -

Xcellerex, a provider of manufacturing technologies, has launched new XDR-10 single-use bioreactor.

The new system, which is available in single-, twin-, triplet-, and quad-vessel configurations, is flexible to handle volumes from 4l to 10l.

The XDR-10 is an integral component of the Xcellerex FlexFactory modular biomanufacturing platform that leverages single-use technology and advanced process automation.

The new system features a low shear, high input-power impeller with optimized position which maximizes volume range and turndown ratio.

The XDR-10 can function as a production vessel in its own right, or become a scale-down tool or satellite platform for larger projects to be continued in larger bioreactors, according to the company.

The flexible platform enables biomanufacturers to speed up deployment of new manufacturing capacity with reduced capital costs and lowered risk.

Latest stories

Related stories

UK Plans to Produce Cancer Treatment from Nuclear Waste

Bicycle Therapeutics has entered into a 15-year agreement with...

Pfizer Signs Around $2.1bn Licensing Deal with YaoPharma

Pfizer has confirmed that it has struck an almost...

€47mn as State Aid for New Aseptic Filling Plant from Vetter

The European Commission has stepped up and given the...

Eli Lilly to Invest over $6bn on the New Huntsville Facility

With an intent to make the incurable curable, Huntsville...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »